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Summary 
Potential economic impact of FMDV carriers is discussed based on some general principles and 
the results of a theoretical example of an FMD-epidemic in the Netherlands. 
Introduction 
Within the field of animal health economics, the main aim is to provide decision makers with 
tools and information to support their decisions related to animal health control (Dijkhuizen and 
Morris, 1997). For FMD control the decisions are made at the national and supra-national level within 
the EU Commision (EU 85/511) and decision support should aim at those levels. No studies on the 
economic effect of FMDV carriers are available, and within our group we have not specifically 
calculated this effect. This presentation will therefore provide a general discussion on the potential 
economic impact of carrier animals within the EU, illustrated with some preliminary quantitative 
results for the Netherlands. 
Economics of FMD epidemics 
Previous research, and recent developments in the UK and the Netherlands, showed that FMD 
epidemics within the EU may be very costly (Meuwissen et aL 1997). For the Netherlands which is an 
exporting country, the direct costs of an FMD or CSF epidemic are of minor importance relative to 
the losses that may occur due to trade restrictions, called indirect costs. However, even the direct costs 
can be very high for the agricultural industry within restricted areas as was calculated for the recent 
Dutch CSF-epidemic (Meuwissen et al, 1999). In general, the total length of the epidemic has a very 
large effect on the total direct and indirect costs related to that epidemic (Mahul et al., 2000). From an 
economic point of view the control efforts should aim at the shortest possible duration, particularly if 
the indirect costs are very high, as for exporting countries. 
General potential economic effect of carriers within the EU 
The economic risk of carrier animals would be introduction of FMD into the EU, re-occurrence 
of FMD within a recent epidemic area, or introduction of FMD into another EU area by movement of 
the carrier animal. For the Dutch situation only cattle, sheep and goat carriers are relevant, as pigs are 
not expected to show carrier status. In our discussion we will assume, firstly, that carrier animals are 
serologically positive and can not be differentiated from non carrier infected animals. Secondly, we 
will assume that carrier animals are infectious for other susceptible animals for a period of 28 - 365 
days post infection, after which they clear the virus. Thirdly, we will define four periods for each 
epidemic as explained below. 
1) Introduction of virus into EU area. 
Undetected infectious carrier animals may be the cause of introduction into the EU. Money can be 
spend on prevention of entrance of seropositive animals, which will automatically include the carriers. 
FMD epidemics may have a very large economic impact, so large costs on prevention of introduction 
may still be economically attractive. The relative risk of introduction by seropositive (carrier) animals 
versus other introduction routes, such as animal products or swill, should be taken into account, 
however. 
2) The high risk period (HRP), when the infection has not yet been detected. 
Carrier animals are of some economical importance only if they can cause spread to other areas 
within the HRP, thereby expanding the subsequent epidemic. However, the HRP within the EU has 
been estimated between 1-4 weeks (Horst et al, 1998). It is therefore much more likely that recently 
infected and infectious animals are moved, instead of carrier animals. 
3) Epidemic period, initial growth followed by decline through control measures. 
Carrier animals are economically not important. All decisions are made on herd level, a few 
positive animals will condemn the whole herd. Herds will be detected based on clinical signs and/or 
serological tests and subsequently culled, including the carrier animals. 
4) Post epidemic period, the area is declared free of infection. 
Undetected carrier animals may be economically very important in this phase. The animals could 
cause re-occurrence of FMD in the same area or in another area up to 1 year after the epidemic is 
declared over. Consequently, trading partners may restrict trade for such a long period. Both a new 
epidemic or a long restriction of trade may be very costly. For this situation, the economic impact of 
carrier animals asks for a closer look, which we will discuss with the Netherlands as example. 
Results of theoretical example for the Netherlands. 
The Dutch FMD contingency plan includes preventive eradication of herds within a radius of 1 
km of the infective herd, as well as emergency vaccination, particularly if the capacity to kill and 
destroy designated animals is not deemed sufficient. All emergency vaccinated herds in the 
Netherlands are currently culled to reduce trade restrictions within the EU from 12 to 3 months. 
Carrier animals within vaccinated herds are thereby destroyed. The economic implications for the 
current Dutch strategy are shown in Table 1. 
Table 1. Indication of expected direct and indirect costs (in Million Dutch guilders) as calculated for a 
hypothetical FMD-epidemic with an HRP of 2 weeks in areas of the Netherlands with various animal 
densities, for two Dutch control strategies. 
Characteristics of 
area similar to 
1 North 
3 'Veluwe' 
4 'Gelderse 
Vallei' 
6 South 
Preventive eradication, radius 1 
Direct 
38 
146 
Endemic 
2123 
km 
Indirect 
2039 
2595 
Endemic 
7387 
Ratio D/I 
.02 
.06 
-
.29 
Vaccination + cull, radius 3 km 
Direct 
51 
169 
445 
830 
Indirect 
2350 
2690 
2963 
4186 
Ratio D/I 
.02 
.06 
.15 
.20 
However, if free trade of emergency-vaccinated animals would be allowed, undetected carrier 
animals from vaccinated herds might become a risk again. The economic value to prevent that risk is 
somewhat quantifiable as follows. We have to assume that a differentiating test is available to detect 
all vaccinated/infected herds, which are subsequently culled. All vaccinated herds that are tested 
FMD-negative are not culled and declared free to trade after a certain period. In such scheme carrier 
animals would again be of no importance, as they are present in the infected herds only, and thus 
culled. Economic results are based on the assumption that vaccinated animals (and products) are 
traded within the EU for the same prices as unvaccinated. Results for this hypothetical situation are 
shown in Table 2. 
Table 2. Indication of expected direct and indirect costs (in Million Dutch guilders) as calculated for a 
hypothetical FMD-epidemic with an HRP of 2 weeks in areas of the Netherlands with various animal 
densities. Differentiation of infected and uninfected vaccinated herds is assumed. Uninfected 
vaccinated herds are not culled and free trade is resumed after 12 or 3 months. 
Characteristics of 
area similar to 
1 North 
3 'Veluwe' 
4 'Gelderse 
Vallei' 
6 South 
12 months export restrictions 
Direct Indirect 
39 2536 
138 3139 
329 3470 
680 5632 
Ratio D/I 
.02 
.04 
.10 
.12 
3 months 
Direct 
39 
138 
329 
680 
export restrictions 
Indirect 
2257 
2511 
2465 
2709 
Ratio D/I 
.02 
.05 
.13 
.25 
Discussion of theoretical example for the Netherlands 
From table 1 it is clear that vaccination is needed to control an FMD epidemic in certain areas of 
the Netherlands. For region 4-like areas, vaccination seems the only possible strategy. The high 
indirect losses are partly caused by the delay in destruction of the vaccinated herds, which delays the 
end of the epidemic. In region 6-like areas, which are very dense, the delay in destruction causes the 
indirect losses to be extremely high in case of vaccination. However, control without vaccination is in 
total even more expensive for such area (9510 million versus 5016), because the epidemic would 
include more infected herds and thus last longer. In region 6-like areas, the direct costs are relatively 
high, which coincides with the calculated direct costs of the Dutch CSF-epidemic in that area 
(Meuwissen et al, 1999). For region 1-like areas, vaccination is not needed to control the epidemic, 
and will only increase the total costs. 
From table 2 it is clear that the length of export restriction has a large impact on the indirect costs, 
which were calculated without price and substitution effects due to the epidemic. The economic effect 
of carrier animals is related to the difference in total losses between the 3 vaccination scenarios. For 
region 6-like areas, vaccination followed by destruction totals 5016 million, vaccination with trade 
after 12 months totals 6312 million, and vaccination with trade after 3 months totals only 3389 
million. For this hypothetical example, the potential risk of export of undetected vaccinated carrier 
animals thus causes the total epidemic costs to rise from around 3 billion to around 6 billion, with the 
current Dutch strategy in between at around 5 billion. 
In conclusion, for certain areas of the Netherlands, emergency vaccination is needed to control an 
FMD-epidemic. The potential risk of carrier animals causes a large increase in the total epidemic 
costs for the Netherlands, because either all vaccinated herds are culled or trade is restricted for a 
minimum of 12 months. Consequently, a lot of money could be spend on the development and 
acceptation by trading partners of a differentiating test for vaccinated herds, because this could lower 
the costs of future Dutch epidemics dramatically. 
Final comments 
All above is based on the assumption that carrier animals are indeed infectious up to 1 year after 
infection and can thus cause the start of an epidemic within that period. This is a very important 
assumption. If carrier animals carry virus but are not infectious, than economically speaking they 
should be of no relevance. In that case, no (research) money should be spend on detection of carier 
animals but more on early detection of infectious animals. If carrier animals are infectious much 
longer than a 1 year period, their economic relevance may be higher, particularly for exporting 
countries that may find their markets closed for a long period. 
For an exporting country within the EU, such as the Netherlands, the main economic impact of 
carrier animals is related to emergency vaccination and the lack of a differentiating test for infected 
and uninfected vaccinated herds. For non-exporting countries, reoccurrence within the own country 
due to carrier animals should be prevented. Control should thus aim at the lowest direct costs, which 
might include a combination of emergency vaccination followed by culling in high density areas. 
In conclusion, 1) a sound scientific indication of the infectiousness and risk of (vaccinated) carrier 
animals and 2) the availability and acceptance of a differentiating test could alter the rules and 
economics of trade dramatically. 
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